{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:49:33Z","timestamp":1776984573337,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","award":["COVID-19 Research Grants Program"],"award-info":[{"award-number":["COVID-19 Research Grants Program"]}],"id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has primarily been achieved using reverse transcriptase polymerase chain reaction (RT-PCR) for acute infection, and serology for prior infection. Assay with RT-PCR provides data on presence or absence of viral RNA, with no information on virus replication competence, infectivity, or virus characterisation. Liquid chromatography-tandem mass spectrometry (LC\u2013MS\/MS) is typically not used in clinical virology, despite its potential to provide supplemental data about the presence of viral proteins and thus the potential for replication-competent, transmissible virus. Using the SARS-CoV-2 as a model virus, we developed a fast \u2018bottom-up\u2019 proteomics workflow for discovery of target virus peptides using \u2018serum-free\u2019 culture conditions, providing high coverage of viral proteins without the need for protein or peptide fractionation techniques. This workflow was then applied to Coronaviruses OC43 and 229E, Influenza A\/H1N1 and H3N2, Influenza B, and Respiratory Syncytial Viruses A and B. Finally, we created an LC\u2013MS\/MS method for targeted detection of the eight-virus panel in clinical specimens, successfully detecting peptides from the SARS-CoV-2 ORF9B and nucleoprotein in RT-PCR positive samples. The method provides specific detection of respiratory viruses from clinical samples containing moderate viral loads and is an important further step to the use of LC\u2013MS\/MS in diagnosis of viral infection.<\/jats:p>","DOI":"10.1038\/s41598-022-16250-y","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T09:02:55Z","timestamp":1659603775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Simultaneous monitoring of eight human respiratory viruses including SARS-CoV-2 using liquid chromatography-tandem mass spectrometry"],"prefix":"10.1038","volume":"12","author":[{"given":"Christopher","family":"Hodgkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"Buckton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Crossett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Cordwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea R.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"16250_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41597-020-00688-8","volume":"7","author":"J Hasell","year":"2020","unstructured":"Hasell, J. et al. A cross-country database of COVID-19 testing. Sci. Data 7, 345. https:\/\/doi.org\/10.1038\/s41597-020-00688-8 (2020).","journal-title":"Sci. Data"},{"key":"16250_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30837-9","author":"EA Meyerowitz","year":"2021","unstructured":"Meyerowitz, E. A., Richterman, A., Bogoch, I. I., Low, N. & Cevik, M. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2. Lancet. Infect. Dis https:\/\/doi.org\/10.1016\/S1473-3099(20)30837-9 (2021).","journal-title":"Lancet. Infect. Dis"},{"key":"16250_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2196-x (2020).","journal-title":"Nature"},{"key":"16250_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638","author":"J Bullard","year":"2020","unstructured":"Bullard, J. et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa638 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"16250_CR5","doi-asserted-by":"publisher","first-page":"104455","DOI":"10.1016\/j.jcv.2020.104455","volume":"129","author":"A Scohy","year":"2020","unstructured":"Scohy, A. et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J. Clin. Virol. 129, 104455. https:\/\/doi.org\/10.1016\/j.jcv.2020.104455 (2020).","journal-title":"J. Clin. Virol."},{"key":"16250_CR6","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.lanwpc.2021.100115","volume":"9","author":"S Muhi","year":"2021","unstructured":"Muhi, S. et al. Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study. Lancet Reg. Health Western Pacific 9, 100115. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100115 (2021).","journal-title":"Lancet Reg. Health Western Pacific"},{"key":"16250_CR7","doi-asserted-by":"publisher","first-page":"2100441","DOI":"10.2807\/1560-7917.ES.2021.26.44.2100441","volume":"26","author":"H Scheiblauer","year":"2021","unstructured":"Scheiblauer, H. et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Eurosurveillance 26, 2100441. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.44.2100441 (2021).","journal-title":"Eurosurveillance"},{"key":"16250_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","volume":"347","author":"AN Hoofnagle","year":"2009","unstructured":"Hoofnagle, A. N. & Wener, M. H. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 347, 3\u201311. https:\/\/doi.org\/10.1016\/j.jim.2009.06.003 (2009).","journal-title":"J. Immunol. Methods"},{"key":"16250_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev-virology-031413-085527","volume":"1","author":"TM Greco","year":"2014","unstructured":"Greco, T. M., Diner, B. A. & Cristea, I. M. The impact of mass spectrometry-based proteomics on fundamental discoveries in virology. Annu. Rev. Virol. 1, 581\u2013604. https:\/\/doi.org\/10.1146\/annurev-virology-031413-085527 (2014).","journal-title":"Annu. Rev. Virol."},{"key":"16250_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0004563214557678","volume":"52","author":"JE Adaway","year":"2015","unstructured":"Adaway, J. E., Keevil, B. G. & Owen, L. J. Liquid chromatography tandem mass spectrometry in the clinical laboratory. Ann Clin Biochem 52, 18\u201338. https:\/\/doi.org\/10.1177\/0004563214557678 (2015).","journal-title":"Ann Clin Biochem"},{"key":"16250_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1128\/JCM.01881-09","volume":"48","author":"A Cherkaoui","year":"2010","unstructured":"Cherkaoui, A. et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48, 1169\u20131175. https:\/\/doi.org\/10.1128\/JCM.01881-09 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"16250_CR12","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.1021\/acs.analchem.5b01544","volume":"87","author":"MW Foster","year":"2015","unstructured":"Foster, M. W. et al. Targeted proteomics of human metapneumovirus in clinical samples and viral cultures. Anal. Chem. 87, 10247\u201310254. https:\/\/doi.org\/10.1021\/acs.analchem.5b01544 (2015).","journal-title":"Anal. Chem."},{"key":"16250_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jviromet.2014.11.014","volume":"213","author":"JA Majchrzykiewicz-Koehorst","year":"2015","unstructured":"Majchrzykiewicz-Koehorst, J. A. et al. Rapid and generic identification of influenza A and other respiratory viruses with mass spectrometry. J. Virol. Methods 213, 75\u201383. https:\/\/doi.org\/10.1016\/j.jviromet.2014.11.014 (2015).","journal-title":"J. Virol. Methods"},{"key":"16250_CR14","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1021\/acs.jproteome.0c00535","volume":"19","author":"D Gouveia","year":"2020","unstructured":"Gouveia, D. et al. Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: A proof-of-concept focused on a 3 min mass spectrometry window. J. Proteome Res. 19, 4407\u20134416. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00535 (2020).","journal-title":"J. Proteome Res."},{"key":"16250_CR15","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1021\/acs.jproteome.0c00412","volume":"19","author":"EN Nikolaev","year":"2020","unstructured":"Nikolaev, E. N. et al. Mass-spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via nucleocapsid N protein. J. Proteome Res. 19, 4393\u20134397. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00412 (2020).","journal-title":"J. Proteome Res."},{"key":"16250_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s42485-020-00044-9","volume":"11","author":"P Singh","year":"2020","unstructured":"Singh, P. et al. A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry. J. Proteins Proteomics 11, 159\u2013165. https:\/\/doi.org\/10.1007\/s42485-020-00044-9 (2020).","journal-title":"J. Proteins Proteomics"},{"key":"16250_CR17","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1021\/acs.jproteome.0c00280","volume":"19","author":"C Ihling","year":"2020","unstructured":"Ihling, C. et al. Mass spectrometric identification of SARS-CoV-2 proteins from gargle solution samples of COVID-19 patients. J. Proteome Res. 19, 4389\u20134392. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00280 (2020).","journal-title":"J. Proteome Res."},{"key":"16250_CR18","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1038\/s41467-020-19925-0","volume":"11","author":"KHM Cardozo","year":"2020","unstructured":"Cardozo, K. H. M. et al. Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts. Nat. Commun. 11, 6201. https:\/\/doi.org\/10.1038\/s41467-020-19925-0 (2020).","journal-title":"Nat. Commun."},{"key":"16250_CR19","doi-asserted-by":"publisher","first-page":"103465","DOI":"10.1016\/j.ebiom.2021.103465","volume":"69","author":"S Renuse","year":"2021","unstructured":"Renuse, S. et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens. EBioMedicine 69, 103465. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103465 (2021).","journal-title":"EBioMedicine"},{"key":"16250_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.02.21258097","author":"A Hober","year":"2021","unstructured":"Hober, A. et al. Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis. medRxiv https:\/\/doi.org\/10.1101\/2021.06.02.21258097 (2021).","journal-title":"medRxiv"},{"key":"16250_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12014-021-09331-z","volume":"18","author":"KK Mangalaparthi","year":"2021","unstructured":"Mangalaparthi, K. K. et al. A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples. Clin. Proteomics 18, 25. https:\/\/doi.org\/10.1186\/s12014-021-09331-z (2021).","journal-title":"Clin. Proteomics"},{"key":"16250_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1021\/jacsau.1c00048","volume":"1","author":"B Van Puyvelde","year":"2021","unstructured":"Van Puyvelde, B. et al. Cov-MS: A community-based template assay for mass-spectrometry-based protein detection in SARS-CoV-2 patients. JACS Au 1, 750\u2013765. https:\/\/doi.org\/10.1021\/jacsau.1c00048 (2021).","journal-title":"JACS Au"},{"key":"16250_CR23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41587-020-0644-7","volume":"38","author":"FM Nachtigall","year":"2020","unstructured":"Nachtigall, F. M., Pereira, A., Trofymchuk, O. S. & Santos, L. S. Detection of SARS-CoV-2 in nasal swabs using MALDI-MS. Nat. Biotechnol. 38, 1168\u20131173. https:\/\/doi.org\/10.1038\/s41587-020-0644-7 (2020).","journal-title":"Nat. Biotechnol."},{"key":"16250_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/v13050730","volume":"13","author":"M Rybicka","year":"2021","unstructured":"Rybicka, M., Mi\u0142osz, E. & Bielawski, K. P. Superiority of MALDI-TOF mass spectrometry over real-time PCR for SARS-CoV-2 RNA detection. Viruses 13, 730. https:\/\/doi.org\/10.3390\/v13050730 (2021).","journal-title":"Viruses"},{"key":"16250_CR25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/clinchem\/hvaa222","volume":"66","author":"JA SoRelle","year":"2020","unstructured":"SoRelle, J. A., Patel, K., Filkins, L. & Park, J. Y. Mass spectrometry for COVID-19. Clin Chem. 66, 1367\u20131368. https:\/\/doi.org\/10.1093\/clinchem\/hvaa222 (2020).","journal-title":"Clin Chem."},{"key":"16250_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41577-020-00493-9","volume":"21","author":"M Veldhoen","year":"2021","unstructured":"Veldhoen, M. & Simas, J. P. Endemic SARS-CoV-2 will maintain post-pandemic immunity. Nat. Rev. Immunol. 21, 131\u2013132. https:\/\/doi.org\/10.1038\/s41577-020-00493-9 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"16250_CR27","doi-asserted-by":"publisher","first-page":"2000107","DOI":"10.1002\/pmic.202000107","volume":"20","author":"D Gouveia","year":"2020","unstructured":"Gouveia, D. et al. Shortlisting SARS-CoV-2 peptides for targeted studies from experimental data-dependent acquisition tandem mass spectrometry data. Proteomics 20, 2000107. https:\/\/doi.org\/10.1002\/pmic.202000107 (2020).","journal-title":"Proteomics"},{"key":"16250_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1080\/22221751.2020.1791737","volume":"9","author":"L Grenga","year":"2020","unstructured":"Grenga, L. et al. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines. Emerg. Microb. Infect. 9, 1712\u20131721. https:\/\/doi.org\/10.1080\/22221751.2020.1791737 (2020).","journal-title":"Emerg. Microb. Infect."},{"key":"16250_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13073-020-00763-0","volume":"12","author":"AD Davidson","year":"2020","unstructured":"Davidson, A. D. et al. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 12, 68. https:\/\/doi.org\/10.1186\/s13073-020-00763-0 (2020).","journal-title":"Genome Med."},{"key":"16250_CR30","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1021\/acs.analchem.0c02288","volume":"92","author":"LH Cazares","year":"2020","unstructured":"Cazares, L. H. et al. Development of a parallel reaction monitoring mass spectrometry assay for the detection of SARS-CoV-2 spike glycoprotein and nucleoprotein. Anal. Chem. 92, 13813\u201313821. https:\/\/doi.org\/10.1021\/acs.analchem.0c02288 (2020).","journal-title":"Anal. Chem."},{"key":"16250_CR31","doi-asserted-by":"publisher","first-page":"e0259165","DOI":"10.1371\/journal.pone.0259165","volume":"16","author":"K Bezstarosti","year":"2021","unstructured":"Bezstarosti, K. et al. Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens. PLoS ONE 16, e0259165. https:\/\/doi.org\/10.1371\/journal.pone.0259165 (2021).","journal-title":"PLoS ONE"},{"key":"16250_CR32","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1038\/s41467-020-17488-8","volume":"11","author":"H-W Jiang","year":"2020","unstructured":"Jiang, H.-W. et al. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nat. Commun. 11, 3581. https:\/\/doi.org\/10.1038\/s41467-020-17488-8 (2020).","journal-title":"Nat. Commun."},{"key":"16250_CR33","doi-asserted-by":"publisher","first-page":"109391","DOI":"10.1016\/j.celrep.2021.109391","volume":"36","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural\/accessory and structural proteins. Cell Rep. 36, 109391. https:\/\/doi.org\/10.1016\/j.celrep.2021.109391 (2021).","journal-title":"Cell Rep."},{"key":"16250_CR34","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.0c00379","author":"NPM Smit","year":"2021","unstructured":"Smit, N. P. M. et al. The time has come for quantitative protein mass spectrometry tests that target unmet clinical needs. J. Am. Soc. Mass Spectrom. https:\/\/doi.org\/10.1021\/jasms.0c00379 (2021).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"16250_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/mas.21543","volume":"39","author":"K Verheggen","year":"2020","unstructured":"Verheggen, K. et al. Anatomy and evolution of database search engines\u2014A central component of mass spectrometry based proteomic workflows. Mass Spectrom. Rev. 39, 292\u2013306. https:\/\/doi.org\/10.1002\/mas.21543 (2020).","journal-title":"Mass Spectrom. Rev."},{"key":"16250_CR36","doi-asserted-by":"publisher","first-page":"13814","DOI":"10.1038\/s41598-018-32072-3","volume":"8","author":"CJ Sande","year":"2018","unstructured":"Sande, C. J. et al. Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics. Sci. Rep. 8, 13814. https:\/\/doi.org\/10.1038\/s41598-018-32072-3 (2018).","journal-title":"Sci. Rep."},{"key":"16250_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14789450.2020.1748502","volume":"17","author":"PV Tomazic","year":"2020","unstructured":"Tomazic, P. V., Darnhofer, B. & Birner-Gruenberger, R. Nasal mucus proteome and its involvement in allergic rhinitis. Expert Rev. Proteomics 17, 191\u2013199. https:\/\/doi.org\/10.1080\/14789450.2020.1748502 (2020).","journal-title":"Expert Rev. Proteomics"},{"key":"16250_CR38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/infdis\/jiaa370","volume":"222","author":"NN Kinloch","year":"2020","unstructured":"Kinloch, N. N. et al. Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results. J. Infect. Dis. 222, 899\u2013902. https:\/\/doi.org\/10.1093\/infdis\/jiaa370 (2020).","journal-title":"J. Infect. Dis."},{"key":"16250_CR39","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","volume":"39","author":"B La Scola","year":"2020","unstructured":"La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1059\u20131061. https:\/\/doi.org\/10.1007\/s10096-020-03913-9 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"16250_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1616","author":"V Gniazdowski","year":"2020","unstructured":"Gniazdowski, V. et al. Repeat COVID-19 molecular testing: Correlation of SARS-CoV-2 culture with molecular assays and cycle thresholds. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1616 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"16250_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvab219","author":"D Evans","year":"2021","unstructured":"Evans, D. et al. The dangers of using Cq to quantify nucleic acid in biological samples: A lesson from COVID-19. Clin Chem. https:\/\/doi.org\/10.1093\/clinchem\/hvab219 (2021).","journal-title":"Clin Chem."},{"key":"16250_CR42","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s10096-020-03930-8","volume":"39","author":"E Farfour","year":"2020","unstructured":"Farfour, E. et al. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1997\u20132000. https:\/\/doi.org\/10.1007\/s10096-020-03930-8 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"16250_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/irv.12799","volume":"15","author":"N Wabe","year":"2021","unstructured":"Wabe, N. et al. Cepheid Xpert\u00ae Flu\/RSV and Seegene Allplex\u2122 RP1 show high diagnostic agreement for the detection of influenza A\/B and respiratory syncytial viruses in clinical practice. Influenza Other Respir. Viruses 15, 245\u2013253. https:\/\/doi.org\/10.1111\/irv.12799 (2021).","journal-title":"Influenza Other Respir. Viruses"},{"key":"16250_CR44","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1021\/acs.jproteome.9b00867","volume":"19","author":"JL Nickerson","year":"2020","unstructured":"Nickerson, J. L. & Doucette, A. A. Rapid and quantitative protein precipitation for proteome analysis by mass spectrometry. J. Proteome Res. 19, 2035\u20132042. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00867 (2020).","journal-title":"J. Proteome Res."},{"key":"16250_CR45","doi-asserted-by":"crossref","unstructured":"Krisp, C. & Molloy, M. P. in Serum\/Plasma Proteomics: Methods and Protocols (eds David W. Greening & Richard J. Simpson) 373\u2013383 (Springer New York, 2017).","DOI":"10.1007\/978-1-4939-7057-5_25"},{"key":"16250_CR46","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2018","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450. https:\/\/doi.org\/10.1093\/nar\/gky1106 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16250-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:11:56Z","timestamp":1669353116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16250-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16250"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16250-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13392"}}